# BrainQ Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brainq-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Jerusalem, Israel
- Website: www.brainqtech.com
- Total disclosed funding: $40M
- Latest round: Series B (Aug 16, 2021)
- Investors on record: 9

## About

BrainQ Technologies Ltd. specializes in developing AI-driven, noninvasive solutions to enhance stroke recovery. Their innovative technology utilizes electromagnetic stimulation to support rehabilitation efforts for stroke survivors.Founded in 2016, BrainQ Technologies Ltd. operates from its headquarters in Jerusalem, Israel. The company focuses on providing advanced rehabilitation solutions through AI-powered technology. Co-founders Esther Shohami, Yaron Segal, and Yotam Drechsler, alongside CEO Alexander Svadkovskiy, have guided the company's development. BrainQ has completed 3 deals, with the latest funding round being a Series B that raised USD 40.00 mn, led by Hanaco Venture Capital and involving various investors including Dexcel Pharma Technologies Ltd. and OurCrowd. This funding reflects a significant milestone for the company as they have raised a total of USD 40.00 mn to date.BrainQ specializes in an innovative, AI-powered, noninvasive solution designed to aid stroke recovery through tailored electromagnetic stimulation. This technology offers a breakthrough approach to rehabilitation by facilitating targeted stimulation of neural networks, which is crucial for maximizing brain learning capabilities. The core product is a device that delivers low-intensity, low-frequency electromagnetic stimulation, allowing users to engage in their recovery process from the comfort of their homes or in clinical settings. The device has been granted FDA Breakthrough Device Designation, indicating its potential to significantly improve patient outcomes. BrainQ serves a diverse clientele, including stroke survivors, rehabilitation clinics, and home care providers, primarily focusing on markets in North America and Europe.BrainQ operates on a business model that includes direct-to-consumer sales and partnerships with rehabilitation clinics. The company generates revenue through the sale of its flagship device, which is marketed to both individual patients and healthcare providers. Transactions are structured around providing the device to consumers and clinics, where users pay for access to the technology aimed at enhancing stroke recovery. The company’s innovative therapy solutions are expected to be part of bundled service offerings in rehabilitation settings, contributing to comprehensive care for stroke patients. Specific pricing structures for the devices and services are integral to their revenue model, reflecting the value placed on enhancing patient independence and recovery efficacy.BrainQ Technologies Ltd. plans to leverage its recent Series B funding of USD 40.00 mn to advance its product offerings and expand into new markets. The company is designing additional products aimed at enhancing recovery processes for stroke patients and anticipates launching these innovations within the next 18 months. Furthermore, BrainQ is targeting expansion into regions in Asia and South America by the end of 2024, aiming to broaden its reach and impact in stroke rehabilitation solutions.

## Funding rounds

- Series B, Aug 16, 2021, $40M — Peregrine Ventures, IT-Farm Corporation, Sailing Capital, OurCrowd, Dexcel Pharma Technologies Ltd., Norma Investment, Hanaco Venture Capital, Qure Ventures, Millhouse Capital

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Series B
- IT-Farm Corporation (https://capitalatlas.ai/funds/it-farm-corporation) — Series B
- Sailing Capital (https://capitalatlas.ai/funds/sailing-capital) — Series B
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series B
- Dexcel Pharma Technologies Ltd. — Series B
- Norma Investment — Series B
- Hanaco Venture Capital (https://capitalatlas.ai/funds/hanaco-venture-capital) — Series B
- Qure Ventures (https://capitalatlas.ai/funds/qure-ventures) — Series B
- Millhouse Capital — Series B